To provide crystal polymorphs of 4-[5-(pyridin-4-yl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile, which is a useful pharmaceutical, and a production method therefor. Through purification of a corresponding salt, recrystallization, or storage under humidified conditions, three different crystal forms; i.e., crystalline polymorphs of 4-[5-(pyridin-4-yl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile are produced.本發明提供一種用作醫藥品之4-[5-(吡啶-4-基)-1H-1,2,4-三唑-3-基]吡啶-2-碳腈之結晶多形及製造方法。本發明係關於一種4-[5-(吡啶-4-基)-1H-1,2,4-三唑-3-基]吡啶-2-碳腈之結晶多形,藉由經由鹽之純化、再結晶或加濕條件下之保存,獲得不同之3種結晶形。